openPR Logo
Press release

Liver Disease Treatment Market to Hit $19,536 million by upcoming Years | GlaxoSmithKline plc, Merck & Co. Inc, Sanofi AG, Pfizer Inc.

10-28-2020 04:52 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Liver Disease Treatment Market

Liver Disease Treatment Market

The Global Liver Disease Market is projected to reach $19.5 billion by 2022, growing at a CAGR of 11.72% during the forecast period, 2016 – 2022. The antiviral drug segment held major share of the total market in 2015 and is expected to maintain its lead throughout the forecast period. This is attributed to the high incidences of virus infected liver diseases including Hepatitis. However, corticosteroid drug segment registered fastest growing segment during the forecast period.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/388

The report segments the global liver disease market based on treatment type and geography. Based on the treatment type, the market is divided into anti-rejection drugs/immunosuppressants, chemotherapy drugs, targeted therapy, vaccines, anti-viral drugs, immunoglobulins, and corticosteroids. The antiviral drugs segment accumulated the highest revenue in 2014 and is expected to continue its dominance through 2022. Meanwhile, the corticosteroids drug segment is projected to grow at the fastest rate, registering a CAGR of 16.5% during the forecast period.

Key findings of the study:

Corticosteroids drug is projected to be the fastest growing segment, registering a CAGR of 16.49% during the forecast period.
North America is expected to lead the market throughout 2022 and is projected to grow at a CAGR of 11.89%, during 2016 and 2022.
Asia-Pacific is expected to grow with a CAGR of around 12.51%, due to increasing prevalence of liver diseases and increasing R&D investments in this region.

Get detailed COVID-19 impact analysis on the Liver Disease Treatment Market:

https://www.alliedmarketresearch.com/request-for-customization/388?reqfor=covid

Key players in the industry-
Gilead Science Inc.
Bayer AG
AstraZeneca PLC
GlaxoSmithKline plc
Merck & Co. Inc
Sanofi AG
Pfizer Inc.
Bristol-Myers Squibb Company
Novartis AJ
Johnson & Johnson Private Limited.

North America and Europe collectively accounted for more than two-fourth of the total liver disease treatment market in 2015, and are expected to maintain their position throughout the forecast period. This is due to the increasing prevalence of liver diseases, growing geriatric population, and increased awareness about the various liver diseases and their treatment in these regions. In addition, advancement in R&D is anticipated in the development of novel drug therapy for the treatment of liver diseases.

Access Full Report @ https://www.alliedmarketresearch.com/liver-diseases-therapeutics-market

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Liver Disease Treatment Market to Hit $19,536 million by upcoming Years | GlaxoSmithKline plc, Merck & Co. Inc, Sanofi AG, Pfizer Inc. here

News-ID: 2175094 • Views: 7489

More Releases from Allied Market Research

Crystal Oscillator Market 2020–2027: Latest Trends, Market Share, Growth Oppor …
Allied Market Research published a new report, titled, "Crystal Oscillator Market By Technology (AT Cut, BT Cut, and SC Cut), Type (Voltage-Controlled Crystal Oscillator, Temperature-Compensated Crystal Oscillator, Oven-Controlled Crystal Oscillator, and Others), Mounting Scheme (Surface Mount and Thru-Hole), and Industry Vertical (Electronics, IT & Telecommunication, Military & Defense, Automotive & Transport, and Others) - Global Opportunity Analysis and Industry Forecast, 2020-2027". The report provides a detailed study of the global crystal
Machine Learning Chip Market 2020-2027: Market Share, Current Trends, Top Impact …
Allied Market Research published a new report, titled, "Machine Learning Chip Market By Chip Type (GPU, ASIC, FPGA, CPU, and Others), Technology (System-on-chip, System-in-package, Multi-chip module, and Others), and Industry Vertical (Media & Advertising, BFSI, IT & Telecom, Retail, Healthcare, Automotive & Transportation, and Others) - Global Opportunity Analysis and Industry Forecast, 2020-2027". The report provides a detailed study of the global machine learning chip market covering a number of important
At 14.4% CAGR, Europe Travel Insurance Market Anticipated to Reach $10.39 Billio …
Allied Market Research published a new report, titled, "Europe Travel Insurance Market By Insurance Cover (Single-Trip Travel Insurance, Annual Multi-Trip Travel Insurance, and Long-Stay Travel Insurance), Distribution Channel (Insurance Intermediaries, Insurance Companies, Banks, Insurance Brokers, and Insurance Aggregators), and End User (Senior Citizens, Education Travelers, Business Travelers, Family Travelers, and Others): Regional Opportunity Analysis and Industry Forecast, 2020-2027". The report provides a detailed study of the global Europe travel insurance market
E-passport Market 2020-2027: Latest Trends, Growth Opportunities, Top Impacting …
Allied Market Research published a new report, titled, "E-passport Market By Technology (Radio Frequency Identification (RFID) and Biometrics) and Application (Leisure Travel and Business Travel) - Global Opportunity Analysis and Industry Forecast, 2020-2027”. The report provides a detailed study of the global e-passport market covering a number of important aspects such as current market scenario, estimates, top investment pockets, recent trends, changing dynamics, and vibrant forces of the industry from 2019

All 5 Releases


More Releases for Liver

Global Liver Detox Market Research Report
This report studies the global Liver Detox market status and forecast, categorizes the global Liver Detox market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Health Plus(UK) Swisse(AU) ReNew Life Formulas, Inc.(US) NATURE' S BOUNTY(US) Healthy Care(AU) Evolution Slimming Ltd(UK) PureFormulas Inc.
Liver Cirrhosis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Liver Cirrhosis - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Cirrhosis - Pipeline Review, H1 2017, provides an overview of the Liver Cirrhosis (Gastrointestinal) pipeline landscape. Cirrhosis is scarring of the liver caused by many forms of liver diseases and conditions, such as hepatitis and
Liver Transplant Rejection - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Liver Transplant Rejection - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Transplant Rejection - Pipeline Review, H1 2017, provides an overview of the Liver Transplant Rejection (Immunology) pipeline landscape. Liver transplantation is the conventional therapy used in various liver diseases. Liver has the unique ability
Global Liver Disease Treatment Market
The Liver Disease Treatment Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. The liver is one of the most important organs of the human body and performs major functions, such as removal of harmful substances from blood, maintains adequate level of chemicals
Liver Extract Power Exporter, Liver Extract Product, Liver Extract Crude, Liver …
Titan Biotech is an ISO 9001:2000 Certified Company, established with an objective of serving Scientific Community and providing good quality of Biological Products, Biotechnology Products, Biological Extracts and their derivatives. Liver Extract Power Exporter is produced from specific fraction of beef liver. Liver Extract is rich in vital nutrients including energy producing B Vitamins and serve as an excellent source of proteins. Liver Extract is capable of stimulating the production
Liver Disease Diagnostics by Immunoblot Test System
Mainz based ORGENTEC Diagnostika GmbH has developed a new immunoblot test for the serological diagnosis of autoimmune liver disease. Liver-9-Line facilitates the rapid and cost-effective diagnosis of autoimmune hepatitis (type 1 and type 2 AIH) and primary biliary cirrhosis (PBC) in a single step. The test system also allows for the reliable differentiation of these autoimmune diseases from other diseases of the liver. This immunoblot is suitable for initial and differential